Reagila Европска Унија - Чешки - EMA (European Medicines Agency)

reagila

gedeon richter - kariprazin hydrochlorid - schizofrenie - psycholeptika - přípravek reagila je indikován k léčbě schizofrenie u dospělých pacientů.

Verzenios Европска Унија - Чешки - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - neoplasmy prsů - antineoplastická činidla - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Emgality Европска Унија - Чешки - EMA (European Medicines Agency)

emgality

eli lilly nederland b.v. - galcanezumab - poruchy migrény - analgesics, galcanezumab - emgality je indikován k profylaxi migrény u dospělých, kteří mají alespoň 4 dny migréna za měsíc.

Cegfila (previously Pegfilgrastim Mundipharma) Европска Унија - Чешки - EMA (European Medicines Agency)

cegfila (previously pegfilgrastim mundipharma)

mundipharma corporation (ireland) limited - pegfilgrastim - neutropenie - imunostimulancia, - zkrácení doby trvání neutropenie a incidence febrilní neutropenie u dospělých pacientů léčených cytotoxickou chemoterapií pro malignitu (s výjimkou chronické myeloidní leukémie a myelodysplastických syndromů).

Baqsimi Европска Унија - Чешки - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - glukagon - diabetes mellitus - pankreatické hormony, hormony glycogenolytic - baqsimi je indikován k léčbě závažné hypoglykémie u dospělých, dospívajících a dětí ve věku 4 roky a starších s diabetes mellitus.

Retsevmo Европска Унија - Чешки - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastická činidla - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Mounjaro Европска Унија - Чешки - EMA (European Medicines Agency)

mounjaro

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, typ 2 - léky užívané při diabetu - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 a 5.

Rayvow Европска Унија - Чешки - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - poruchy migrény - analgetika - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

CIFLOXINAL 250MG Potahovaná tableta Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

cifloxinal 250mg potahovaná tableta

pro.med.cs praha a.s. array - 9564 monohydrÁt ciprofloxacin-hydrochloridu - potahovaná tableta - 250mg - ciprofloxacin

CIGENTA 136MMOL/L Infuzní roztok Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

cigenta 136mmol/l infuzní roztok

fresenius medical care deutschland gmbh, bad homburg array - 1323 dihydrÁt natrium-citrÁtu - infuzní roztok - 136mmol/l - hemofiltraČnÍ roztoky